This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Aug 12;368(9535):555-6.

doi: 10.1016/S0140-6736(06)69172-1.

Overview of randomised trials of ACE inhibitors

Giuseppe Remuzzi¹, Piero Ruggenenti

Affiliations

PMID: 16905000
DOI: 10.1016/S0140-6736(06)69172-1

Comment

Overview of randomised trials of ACE inhibitors

Giuseppe Remuzzi et al. Lancet. 2006.

. 2006 Aug 12;368(9535):555-6.

doi: 10.1016/S0140-6736(06)69172-1.

Authors

Giuseppe Remuzzi¹, Piero Ruggenenti

Affiliation

¹ Mario Negri Institute for Pharmacological Research and Unit of Nephrology and Dialysis, Ospedali Riuniti, Bergamo 24125, Italy. gremuzzi@marionegri.it

PMID: 16905000
DOI: 10.1016/S0140-6736(06)69172-1

No abstract available

PubMed Disclaimer

Comment in

Overview of randomised trials of ACE inhibitors.
Bonne JF, Fournier A, Massy Z, Choukroun G, Fournier A. Bonne JF, et al. Lancet. 2006 Sep 30;368(9542):1152-3. doi: 10.1016/S0140-6736(06)69468-3. Lancet. 2006. PMID: 17011937 No abstract available.

Comment on

Angiotensin-converting-enzyme inhibitors in stable vascular disease without left ventricular systolic dysfunction or heart failure: a combined analysis of three trials.
Dagenais GR, Pogue J, Fox K, Simoons ML, Yusuf S. Dagenais GR, et al. Lancet. 2006 Aug 12;368(9535):581-8. doi: 10.1016/S0140-6736(06)69201-5. Lancet. 2006. PMID: 16905022

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal